Dear Oxfordshire Primary Care Trust (PCT),
I would like to know how many clinicians have been using the drug Avastin (bevacizumab) to treat patients with the eye conditions: wet age related macular degeneration and diabetic macular oedema between the 1st of January 2011 to the 1st of August 2012.
I would like the lists to separate - one for wet AMD, the other for DMO.
Dear Mr Adam's,
Please find attached our acknowledgement letter for your Freedom of Information request.
With kind regards
Freedom of Information Team
NHS Buckinghamshire and Oxfordshire Cluster
01865 334 650
In reference to your FOI request below, the PCT does not hold this information. Please redirect your query to:
Rachael Demain | Freedom Of Information Officer | NHS Buckinghamshire & Oxfordshire Cluster, Jubilee House, 5510 John Smith Drive, Oxford Business Park, Cowley, Oxford, OX4 2LH
|tel: 01865 334650 | email: [email address]| web: www.oxfordshirepct.nhs.uk
Follow us on Facebook ● Follow us on Twitter ● Come and Talk Health
For Freedom Of Information requests please email [NHS Oxfordshire request email]
Pager number: 07659 129167 This is the number to page a member of the communications team between 5pm – 9am, Monday to Friday and 24 HOURS at weekends and bank holidays.
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.Donate Now